Therefore, the MDM2 inhibitor Nutlin-3a can be used to activate p53, which subsequently induces the expression of PVR, a ligand of the NK cell receptor DNAM-1, resulting in enhanced NK cell killing by neuroblastoma.48 The gene discussed is CD226; the disease is neuroblastoma.